Head-to-head · Value Score
Eden vs Mint Med
Two GLP-1 deals, scored on the same six factors. Eden lands a Value Score of 91, Mint Med a 85. Compare their advertised prices, billing terms, and what to check before paying.
Eden
Grade A · Excellent
Advertised price
$99/mo
$99/mo (compounded semaglutide injection)
Save ~72% vs brand self-payMint Med
Grade A- · Great Deal
Advertised price
$106/mo
$106/mo (all doses)
Save ~70% vs brand self-payThe verdict
Eden takes it on Value Score, 91 to 85 — at an advertised price of $99/mo (compounded semaglutide injection). We found no advertised teaser step-up. Mint Med isn't out of it: Someone in a supported state who prefers a monthly semaglutide bill and wants to compare a quarterly tirzepatide discount against flexibility. I would confirm the prescribed product and state eligibility before choosing a plan, then keep its processing date and cancellation instructions with the payment receipt.
If neither program settles it, the RxSpan MD review and the HumeCare+ review cover two other programs we partner with, and each sets out its price and billing terms so you can run the same comparison.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Eden | Mint Med |
|---|---|---|
| Value Score | 91 (A) | 85 (A-) |
| Advertised price | $99/mo (compounded semaglutide injection) | $106/mo (all doses) |
| Save vs brand self-pay | ~72% | ~70% |
| Semaglutide | $99/mo | $106/mo (all doses) |
| Tirzepatide | $129/mo | $179/mo month-to-month ($150/mo on a 3-month plan) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | Published list of 36 states (FAQ also says 35; confirm eligibility) |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Eden
Eden’s current compounded injection plans advertise $99 monthly semaglutide and $129 tirzepatide including care, but its older offers and warranty terms still need clarification before you pay.
Why it's a deal
- Eden’s current GLP-1 pages include provider review, clinical support, 24/7 messaging, dosing and side-effect guidance, priority delivery and a member community in the monthly price. No insurance is required, and the offer is marked HSA/FSA eligible; those inclusions help make the advertised $99 and $129 useful starting points for a household budget.
- Eden says the starting price remains protected while your account stays active, including permitted pauses. Closing the account and returning later means accepting the price then available, so a pause and a permanent cancellation have different consequences for anyone hoping to preserve today’s rate.
- Eden identifies Dr. Rebecca Emch as its VP of Pharmacy Operations, Dr. Halland Chen as Chief Medical Innovation Officer and Savannah King as an Eden Pharmacy pharmacist. Naming the people responsible for pharmacy operations and clinical development gives you something concrete to evaluate beyond a generic promise of doctor-guided care.
- Eden’s about page names GoGoMeds, Precision, Enovex and AbsolutePharmacy and publishes their locations; its current product FAQ says prescriptions may come from Eden Pharmacy or vetted U.S. partners. The company also states its pharmacy and provider network serves all 50 states and Washington, D.C., though that does not guarantee eligibility for every individual treatment.
- Eden’s separate refund policy provides a prorated refund for prepaid medication that cannot be supplied, calculated from the unshipped portion. It also offers an alternative treatment and says approved refunds are processed within 30 days; this gives readers a stated remedy for supply interruptions rather than an assumption that prepaid funds disappear.
The fine print
- Eden’s product pages advertise a warranty for losing at least 15% in six months, but its terms describe a 10% threshold after 26 consecutive weekly doses and limit refunds to eligible membership fees. For a plan advertised without membership fees, the refund amount needs written clarification.
- Eden’s guarantee terms require weekly check-ins, weekly posts in its private Facebook group and verification videos, including an initial video within 15 days. The refund promise is conditional on documented participation, so readers uncomfortable with those requirements should not count it as automatic protection.
- Eden allows portal cancellation, but orders already sent to the pharmacy may continue. General subscription terms require cancellation before billing; the separate membership program requires 48 hours’ notice, and processed prescription charges are generally nonrefundable, so cancel before an order advances rather than waiting for shipment.
- Eden’s older branded-treatment and GLP-1 pages still show a $39 introductory membership that renews at $99 monthly. Those pages do not establish the checkout total for the current $99/$129 injection offer; ask support to identify the applicable program and recurring charge instead of combining incompatible prices.
- Eden’s lifetime-price headline sits alongside terms reserving price changes and excluding introductory promotions from its same-dose offer. I would keep the enrollment price and written renewal terms rather than assume every discount receives the lifetime protection described in the current FAQ.
- FDA issued a June 2026 warning letter to Eden about misleading compounded-drug labeling and pharmacy claims. Eden’s current pages disclose that compounded medications are not FDA-approved, but branding and quality-control promises do not substitute for FDA review of the dispensed product.
Mint Med
Mint Med combines a low advertised semaglutide rate with clearly priced monthly and quarterly tirzepatide options. My main reservations are its inconsistent state count and cancellation terms that can make a prepaid discount costly to unwind.
Why it's a deal
- Mint Med continues to advertise semaglutide at $106 per month across doses and states that there is no membership. That makes the main semaglutide offer easier to compare than a medication price accompanied by a separate subscription charge. Confirm the final order total and prescribed supply rather than applying the general banner to every product.
- Mint Med separates its tirzepatide payment choices on the current product page: $179 billed every month or $450 every three months. The quarterly equivalent is $150 a month, but the amount due is $450. Seeing both figures helps you decide whether the savings justify paying ahead instead of comparing only the smaller equivalent.
- Mint Med says the online process includes a medical history review, a provider assessment, a telehealth visit when needed and ongoing portal messaging. The FAQ explains that states have different live-visit requirements. I would check how to arrange follow-up before enrolling rather than assuming routine messages always include an appointment.
- Mint Med says payment is collected before the clinical review, and its FAQ promises an immediate refund when the clinician finds an applicant medically ineligible. That protects a different situation from changing your mind after approval; keep the eligibility decision and payment confirmation if a refund needs follow-up.
- Mint Med publishes a U.S. support telephone number, weekday office hours and HSA/FSA eligibility. Its tirzepatide page also states that delivery is free. These are practical service details, although using a benefit account does not establish that every purchase qualifies under your particular account rules.
The fine print
- Mint Med has inconsistent coverage information: its homepage says 35 states, while the explicit state list contains 36. That does not support nationwide availability. Check your state and selected treatment before paying, especially if you are moving or expecting a prescription to follow you between states.
- Mint Med requires cancellation through its official form at least 48 business hours before the next order processing date. That is not simply two calendar days before a shipment. Its policy says late requests cannot be honored and processing makes an order final, so submit well in advance and retain confirmation.
- Mint Med says some subscriptions involve prepaid three-, six- or twelve-month terms. Canceling before completing one can require paying the difference between the promotional and full price. The monthly equivalent therefore does not describe the entire financial obligation; ask how this rule applies to the exact plan you select.
- Mint Med generally makes consultation fees nonrefundable after a provider visit unless the applicant is medically ineligible, and processed prescription orders cannot be refunded even before shipment. Its return restrictions mean an unused supply is not automatically refundable. The eligibility promise should not be read as a trial period.
- FDA issued a June 2026 warning letter to Glow Medispa, LLC doing business as Mint Med; the public regulatory record is linked on this review. Its current pages disclose that compounded medication is not FDA-approved. Ask which pharmacy will dispense your prescription; the platform says actual pharmacy, packaging and labeling may vary.
We earn a commission when you start treatment through some links on this site, at no extra cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Eden is ranked on the Eden alternatives ranking, and the same list for the other side is on alternatives to Mint Med.
More head-to-heads
The programs scoring closest to this pair, side by side.
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. "% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on each provider's site. Not medical advice; see our disclosure.